Table 2.

Efficacy of docetaxel-platinum and docetaxel single-agent group

	Docetaxel-platinum group (n=44)	Docetaxel group (n=41)	P-value
Complete response	0	0	–
Partial response	13	8	–
Stable disease	14	13	–
Progressive disease	17	20	–
Response rate	29.5%	19.5%	0.28
Disease control rate	61.4%	51.2%	0.35
Median progression-free survival	3.6 months	3.2 months	0.38
Median overall survival	5.7 months	5.2 months	0.64